Sankyo signs up Singapore pharma for natural product leads
Thursday, 21 April, 2005
Private Singapore natural products company MerLion Pharmaceuticals has sealed a three-year cooperative drug discovery and development collaboration with Japan's Sankyo.
The companies will collaborate on both the lead discovery and optimisation stages of the collaboration. Sankyo will provide selected high-throughput screens and additional assays to MerLion, which will provide access to its sample collection. Sankyo will undertake clinical development and commercialisation of the discoveries.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...